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ABSTRACT
Introduction: Cutaneous neoplasms are the most common cancers in the world, 
and have high morbidity rates. A definitive diagnosis can only be obtained after 
histopathological evaluation of the lesions. To develop an artificial intelligence program 
to establish the histopathological diagnosis of cutaneous lesions.
Methods: A deep learning program was built using three neural network architectures: 
MobileNet, Inception and convolutional networks. A database was constructed using 
2732 images of melanomas, basal and squamous cell carcinomas, and normal skin. 
The validation set consisted of 284 images from all 4 categories, allowing for 
the calculation of sensitivity and specificity. All images were provided by the 
Path Presenter website.
Results: The sensitivity and specificity of the MobileNet model were 92% (95%CI, 
83-100%) and 97% (95%CI, 90-100%), respectively; corresponding figures for 
the Inception model were 98.3% (95%CI, 86-100%) and 98.8% (95%CI, 98.2-100%); 
lastly, the sensitivity and specificity of the convolutional network model were 91.6% 
(95%CI, 73.8-100%) and 95.7% (95%CI, 94.4-97.2%). The maximum sensitivity for 
the differentiation of malignant conditions was 91%, and specificity was 95.4%.
Conclusion: The program developed in the present study can efficiently distinguish 
between the main types of skin cancer with high sensitivity and specificity.
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INTRODUCTION
Artificial intelligence (AI) systems consist of computer programs that 
replicate human reasoning and its characteristic features such as learning, 
creativity and responsiveness. AI systems differ from human reasoning in 
that they are fast, autonomous and have no physiological needs. They are 
therefore able to outperform humans on a variety of tasks, including those 
in the medical domain1-3.
Radiology and pathology are two areas that could benefit from the use of AI. 
Both specialties involve a need to recognize visual patterns in order to perform 
an accurate pathological diagnosis. Computers are extremely efficient at this 
type of task, as evidenced by findings from non-medical studies of facial and 
object recognition4,5.
Currently, AI technologies such as IBM’s Watson system are used to 
evaluate oncology patients and assist in the choice of chemotherapy drugs 
for specific cancer types and clinical conditions6.
Other technological systems have also been used to evaluate microscopic 
skin lesions and differentiate between benign and malignant disease; 
in these tasks, AI systems have outperformed human clinicians7.
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The evaluation of skin lesions is a highly important 
procedure, as cutaneous neoplasms are the most 
common cancers in the world.The most prevalent 
histological subtypes are basal cell carcinoma (BCC), 
squamous cell carcinoma (SCC), and malignant 
melanoma (MM). However, the diagnosis of these 
conditions can only be confirmed by microscopic 
histological evaluation8,9.
An AI algorithm based on deep learning was 
developed to diagnose the most important cutaneous 
pathologies, such as BCC, SCC, and MM, and 
distinguish these from histologically normal skin.
METHODS
Software development
An deep-learning AI system was developed with 
three analysis options: one did not use a neural network 
library, while the other two used the Inception V3 and 
MobileNet models. The software structure consisted 
of sets of overlapping algorithms divided into several 
processing tiers, with each round involving several 
linear and nonlinear transformations. A computerized 
communication interface was established to perform 
the histopathological evaluation of cutaneous images 
at increasing levels of magnification (40-100x).
The image processing algorithm was implemented 
in Python 3, a systematic, block-based programming 
language. It is a dynamic method that allows for 
the creation of a learning network to catalogue 
the pathologies. The programming languages 
PHP 7 and JavaScript were then used to create 
a n graphic user interface, where options and 
commands could be selected using tools such as 
buttons and scroll bars.
The software was named KAi (Kuiava Artificial 
Intelligence). Image resolution was 224x224 pixels 
for MobileNet, 299x299 for Inception and 128x128 
for the convolutional network. Images were analyzed 
using R, G and B channels.
Database construction and selection of  
histopathological slides
The algorithms were trained using the open-
source library TensorFlow. The pre-trained models 
MobileNet 1.0 and Inception 3 were used, along with 
an exclusive database of histopathological images. 
The database contained pre-analyzed images obtained 
from Google Inc.
Histopathological images of cutaneous tissue slides 
at multiple magnifications, classified as normal, BCC, 
SCC and melanoma, were obtained from the Path 
Presenter website. A total of 2,732 images were 
used to create the training database. All images 
were reevaluated by two pathologists to confirm 
the original classification. The images were then 
analyzed by an AI system to create the database.
The preliminary results yielded a reliability of 
97.5% for MobileNet; 97.8% for Inception and 97% 
for the convolutional network.
Software validation
After the initial evaluation, an efficiency test was 
performed in three phases:
Stage one: Fifty-one histopathology slides with or 
without lesions were selected, from which 754 images 
were obtained and rotated at 90, 180 and 270 degrees 
to expand the database. This resulted in a final set 
of 3,016 images.
Stage two: Two image groups were created, one 
with 284 images to test and validate the system, and 
another with 2,732 images to develop the program.
Stage three: The Jpeg images were processed 
and analyzed by the KAi software to provide 
a diagnosis.
Statistical analysis
The data generated by the software was exported 
to a Microsoft Excel spreadsheet. Sensitivity and 
specificity were calculated using the following 
formula: sensitivity = true positives/total positives; 
specificity = true negatives/total negatives. Hit-rates 
were compared using ANOVA, and results were 
considered significant at a 5% level. SSPS 10.0 was 
used for the analyses.
Ethical considerations
This research project was submitted to the Ethics 
Committee of the University of Passo Fundo, and 
approved under number 25973719.9.0000.5342, 
on February 14th, 2020.
RESULTS
A computer program was developed to analyze 
histopathological images of skin lesions and detect 
the presence of cancer. The layout and functionality 
of the program are shown in Figure 1 A-B.
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1. Select images for analysis. 2. Select the analysis method. 3. Access the report.
Drag and drop or click to upload
Images for analysis Analyze with Reports
Figure 1: Initial program interface, showing the layout, function options and reports. A: Home page; B: Results.
The program database included 12 melanoma 
slides, 16 SCC, 13 BCC and 10 normal skin slides. 
The slides were used to generate 868 melanoma 
images, 652 SCC, 680 BCC and 532 normal skin 
images. The validation set consisted of 80 melanoma 
images, 72 each for BCC and SCC, and 60 images 
of normal skin – see Table 1 and Figure 2.
Sensitivity and specificity were calculated for each 
of the models. The sensitivity of the MobileNet model 
was 92% (95%CI, 83-100%), and its specificity, 97% 
(95%CI, 90-100%).
For the Inception model, sensitivity was 98.3% 
(95%CI, 86-100%) and specificity, 98.8% (95%CI, 
98.2-100%). Lastly, for the convolutional network 
model, sensitivity was 91.6% (95%CI, 73.8-100%) and 
specificity was 95.7% (95%CI, 94.4-97.2%) – Table 2.
Table 1: Variables used to construct the program database. 
Histology Slides Database images Test Total
Basal cell carcinoma 13 680 72 752
Squamous cell 
carcinoma 16 652 72 724
Melanoma 12 868 80 948
Normal Skin 10 532 60 592
Total 51 2732 284 3016
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Figure 2: Examples of histopathological images used in construction. A: Normal Skin; B: In Situ Carcinoma; C: Melanoma; 
Basal Cell Carcinoma.
Table 2: Sensitivity and specificity for the diagnosis of different pathological alterations. 
Histology Mobile  Inception  Convolutional
Basal cell carcinoma Sensitivity 0.8194 0.8472 0.6667
Specificity 0.9955 0.9909 0.9409
Squamous cell carcinoma Sensitivity 0.9861 1.0000 1.0000
Specificity 0.9636 0.9682 0.9773
Melanoma Sensitivity 0.8750 0.8977 1.0000
Specificity 0.9955 0.9996 0.9545
Normal skin Sensitivity 1.0000 0.9833 0.9167
Specificity 0.9318 0.9961 0.9591
Total Sensitivity 0.9201 0.9321 0.8958
Specificity 0.9716 0.9887 0.9580
The maximum sensitivity and specificity for 
the differentiation of malignant lesions were 91% and 
95.4%, respectively. With regards to the detection 
of malignant conditions, maximum sensitivity was 
98.3% and specificity was 99.6%. There were no 
statistical differences in sensitivity and specificity 
between the MobileNet, Inception and Convolutional 
network models (p=0.769).
DISCUSSION
The global incidence of cancer is expected to 
increase in the following years, mainly as a result of 
population aging10. Skin cancers are the most common 
malignancy in the world. Skin lesions are a major cause 
of morbidity and, in some cases, mortality. A definitive 
diagnosis of these cases requires a histological analysis 
of the lesions7,9. Fortunately, computer programs might 
be able to assist with histological diagnosis11-13.
Computer programs based on AI have the capacity 
to make significant contributions to the health sector. 
So far, these techniques have produced encouraging 
results, with software programs demonstrating high 
sensitivity and specificity, and emerging as a promising 
complement to the histopathological evaluation of 
cutaneous lesions14.
Medical assistance is a crucial part of patient care. 
The need for a careful evaluation of the clinical and 
individual characteristics of each patient makes it 
unlikely that the entire population of health care 
workers would be replaced by technology5.
Recent discussions on the future of medicine have 
identified areas such as radiology and pathology 
where technology may be an important tool to 
assist professionals in providing a fast and accurate 
diagnosis, reducing patient waiting lists and improving 
medical procedures1,15.
This is a promising alternative for Brazil, a country 
with an uneven distribution of medical specialists16, 
and where the adoption of technological tools could 
contribute significantly to the quality of health care17. 
Additionally, technological development may stimulate 
the economy and improve the qualification of health 
care professionals17.
Limitations of the program developed in the present 
study include difficulties in diagnosing lesions in the early 
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stages of cancer or with intense inflammation. Structural 
difficulties may emerge due to variations in the way 
images are digitized in each institution, although 
this can be minimized by increasing the variability of 
images in the program database14.
Strengths of the program include its intuitive 
interface and the use of a database containing 
histologic images of cutaneous neoplasms to test and 
validate the program. The slides were obtained from 
the Path Presenter library, which receives data from 
several institutions and pathologists. The resulting 
variability in these images contributes to a reliable 
diagnosis of skin lesions.
Computer programs based on AI have the capacity 
to improve patient care. The software developed 
in the present study demonstrated high sensitivity 
and specificity, with values of 93 and 98.8%, 
respectively. The application of technology in health 
care might contribute to the speed and efficacy of 
medical evaluations.
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